142 related articles for article (PubMed ID: 37805879)
1. TESTOSTERONE AND SERUM ZINC LEVELS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA.
Radhi G; Hilal N; Abdul-Aziz M
Georgian Med News; 2023; (340-341):81-86. PubMed ID: 37805879
[TBL] [Abstract][Full Text] [Related]
2. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
[TBL] [Abstract][Full Text] [Related]
3. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
5. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.
Marberger M; Roehrborn CG; Marks LS; Wilson T; Rittmaster RS
J Clin Endocrinol Metab; 2006 Apr; 91(4):1323-8. PubMed ID: 16434455
[TBL] [Abstract][Full Text] [Related]
6. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
[TBL] [Abstract][Full Text] [Related]
8. Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists.
Trumble BC; Stieglitz J; Eid Rodriguez D; Cortez Linares E; Kaplan HS; Gurven MD
J Gerontol A Biol Sci Med Sci; 2015 Oct; 70(10):1262-8. PubMed ID: 25922348
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.
Tan MO; Karabiyik I; Uygur MC; Diker Y; Erol D
Int Urol Nephrol; 2003; 35(3):357-63. PubMed ID: 15160539
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
[TBL] [Abstract][Full Text] [Related]
11. [Endocrine environment of benign prostatic hyperplasia--relationships of sex steroid hormone levels with age and the size of the prostate].
Suzuki K; Inaba S; Takeuchi H; Takezawa Y; Fukabori Y; Suzuki T; Imai K; Yamanaka H; Honma S
Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):664-71. PubMed ID: 1379658
[TBL] [Abstract][Full Text] [Related]
12. Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels.
Kim WT; Yun SJ; Choi YD; Kim GY; Moon SK; Choi YH; Kim IY; Kim WJ
J Korean Med Sci; 2011 Sep; 26(9):1214-8. PubMed ID: 21949470
[TBL] [Abstract][Full Text] [Related]
13. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
[TBL] [Abstract][Full Text] [Related]
14. Potential of telmisartan in the treatment of benign prostatic hyperplasia.
Ishola IO; Anunobi CC; Tijani KH; Afolayan O; Udokwu VU
Fundam Clin Pharmacol; 2017 Dec; 31(6):643-651. PubMed ID: 28727906
[TBL] [Abstract][Full Text] [Related]
15. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
16. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623
[TBL] [Abstract][Full Text] [Related]
17. Bawu decoction () ameliorates benign prostatic hyperplasia in rats.
Eom JH; Cheon SY; Chung KS; Kim MD; An HJ
Chin J Integr Med; 2017 Aug; 23(8):611-616. PubMed ID: 27838873
[TBL] [Abstract][Full Text] [Related]
18. Impact of Prostate Specific Antigen and Testosterone Hormone Levels in Patients of Benign Prostatic Hyperplasia in Khartoum State-Sudan.
A M Alameen A; A M Osman T; A Elissidig S; Atif M
Pak J Biol Sci; 2020 Jan; 23(11):1431-1435. PubMed ID: 33274871
[TBL] [Abstract][Full Text] [Related]
19. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
[TBL] [Abstract][Full Text] [Related]
20. Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia.
Stone NN; Clejan SJ
J Androl; 1991; 12(6):376-80. PubMed ID: 1722793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
